Neurovia
San Francisco, US · Founded 2013 · Delaware corporation
Founders & leadership
GF
Giovanni FerraraExecutive
TS
Thomas S. ScanlanNamed on SEC filing
Board
HS
Henry SkinnerBoard director
JH
Jason HaflerBoard director
Reported raises · per SEC filings
Form D private placements$13.9M disclosed across 1 round · 2015
▶$13.9MraisedMay 2017 · 8 investors · PharmaceuticalsRule 506(b)
▶$13.9MraisedMay 2017 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Henry SkinnerDirector
- Thomas S. ScanlanExecutive Officer, Director
- Giovanni FerraraExecutive Officer, Director
- Jason HaflerDirector
- Amount sold
- $13.9M
- Minimum investment
- $25K
- First sale
- Nov 2015
- Incorporated
- Corporation, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Neurovia raised?
- Neurovia has disclosed $13.9M raised across 1 round.
- Where is Neurovia headquartered?
- Neurovia is headquartered in San Francisco, US.